Action Tesa launches nanotech-based  antimicrobial coating for boards
Products

Action Tesa launches nanotech-based antimicrobial coating for boards

Action Tesa has launched TESA Antiviro, an antimicrobial coating in pre-laminated boards. The company says the product is suitable in making furniture items for any high public traffic areas such as hospitals, health and spa institutions, educational institutions, malls, airports and hotels.

According to the company, TESA Antiviro surfaces are made with nanotechnology, in which nano-particles continuously release ions which is a mechanism for killing microbes like bacteria, viruses, fungus etc. Owing to the electrostatic attraction, these nanoparticles physically rupture the cell wall and cytoplasmic membrane of the microbes and viruses that come in contact with TESA Antiviro surfaces. The company stated that the nanoparticles are effective throughout the life of the product.

Use of nano technology is increasing in medical science and also an alternative to antibiotics. Nanoparticles based coating is also being used for coating in medical equipment.Tesa Antiviro products have been tested by Mumbai-based Biotech Testing Services for antimicrobial activity against JIS Z 2801 test method and for measurement of antiviral activity against test standard ISO 21702:2019, result of which shows 99.99% microbial kill.

Written from a news release.

Action Tesa has launched TESA Antiviro, an antimicrobial coating in pre-laminated boards. The company says the product is suitable in making furniture items for any high public traffic areas such as hospitals, health and spa institutions, educational institutions, malls, airports and hotels. According to the company, TESA Antiviro surfaces are made with nanotechnology, in which nano-particles continuously release ions which is a mechanism for killing microbes like bacteria, viruses, fungus etc. Owing to the electrostatic attraction, these nanoparticles physically rupture the cell wall and cytoplasmic membrane of the microbes and viruses that come in contact with TESA Antiviro surfaces. The company stated that the nanoparticles are effective throughout the life of the product. Use of nano technology is increasing in medical science and also an alternative to antibiotics. Nanoparticles based coating is also being used for coating in medical equipment.Tesa Antiviro products have been tested by Mumbai-based Biotech Testing Services for antimicrobial activity against JIS Z 2801 test method and for measurement of antiviral activity against test standard ISO 21702:2019, result of which shows 99.99% microbial kill. Written from a news release.

Related Stories

Gold Stories

Next Story
Resources

Schindler named among Forbes’ World’s Best Employers 2026

Schindler has been named among Forbes’ World’s Best Employers 2026, a global ranking recognising companies for their workplace environments.Compiled by Forbes in partnership with Statista, the ranking is based on independent employee feedback, including whether employees would recommend their organisation to friends and family.The company said the recognition reflected its focus on creating a workplace where employees can develop their expertise and build careers. ..

Next Story
Infrastructure Urban

India needs an export-execution mindset: Vishesh Jain

Interview with Vishesh Jain, Founder & CEO, EximpleWhat gaps in India’s global trade ecosystem led you to build Eximple, and what problem did you see businesses struggling with most?Eximple came out of a problem that all three founders had seen from different choke points in the trade ecosystem. India has millions of MSMEs and manufacturers, and many of them can make products that are genuinely competitive on quality. Yet only a small fraction is able to build meaningful international businesses. In our experience, the gap is usually not manufacturing capability; it is the ability to exe..

Next Story
Building Material

Nuvoco reports 13.5% revenue growth in Q2 FY27

Nuvoco Vistas Corp. Ltd. reported consolidated revenue of Rs 27.9 billion for Q2 FY27, up 13.5% year on year. Cement sales volume rose 9% to 4.7 million tonnes (MMT), while EBITDA increased 11% to Rs 4.11 billion.The company said it began its cement operations in 2014 with a 2.3 MMT per annum (MMTPA) operation at Nimbol. It now aims to reach 35 MMTPA of cement capacity by FY28, nearly 15 times its initial capacity. Its portfolio spans cement, ready-mix concrete and modern building materials.On sustainability and cost efficiency, Nuvoco partnered with CleanMax for a 46.4 MW wind-solar hybrid re..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

SPECIAL OFFER
QR Code